- If you are considering taking RINVOQ, you should know that12:
- Your healthcare provider (HCP) should test you for TB before starting RINVOQ and check you closely for signs and symptoms of TB during treatment with RINVOQ.
- You should not start taking RINVOQ if you have any kind of infection unless your HCP tells you it is okay.
- Your HCP should do blood tests before you start taking RINVOQ and while you take it.
- Your HCP may stop your RINVOQ treatment for a period of time if needed because of changes in these blood test results.
- Do not take RINVOQ if you are allergic to upadacitinib or any of the ingredients in RINVOQ.
Learn more:✕This summary was generated using AI based on multiple online sources. To view the original source information, use the "Learn more" links.Your healthcare provider (HCP) should test you for TB before starting RINVOQ and check you closely for signs and symptoms of TB during treatment with RINVOQ. You should not start taking RINVOQ if you have any kind of infection unless your HCP tells you it is okay.www.rinvoq.com/ulcerative-colitisYour HCP should do blood tests before you start taking RINVOQ and while you take it. Your HCP may stop your RINVOQ treatment for a period of time if needed because of changes in these blood test results. Do not take RINVOQ if you are allergic to upadacitinib or any of the ingredients in RINVOQ.www.rinvoq.com/rheumatoid-arthritis/getting-rinvoq… - People also ask
RINVOQ® (upadacitinib) | Official Healthcare Professional Site
WEBRINVOQ is indicated for the treatment of: Moderately to severely active rheumatoid arthritis (RA) in adults who have had an inadequate response or intolerance to one or more …
See results only from rinvoqhcp.comChoose an Indication
View info for healthcare professionals about RINVOQ®, a treatment for moderate to …
Patient Support
RINVOQ® Complete provides support to help your patients start and stay on track …
Resources & Forms
IMPORTANT SAFETY INFORMATION & INDICATIONS 1 INDICATIONS 1. …
Psoriatic Arthritis
View information for healthcare professionals about RINVOQ®, a …
Atopic Dermatitis
INDICATION & IMPORTANT SAFETY INFORMATION 1 INDICATION 1. …
Ulcerative Colitis
U-ACHIEVE MAINTENANCE Study Design Intro: 1 52-week, double-blind, placebo …
Access & Support
Find RINVOQ full prescribing information, including BOXED WARNING and …
RINVOQ® (upadacitinib) Treatment for RA, PsA, AD, …
WEBWhat should I tell my HCP BEFORE starting RINVOQ? Tell your HCP if you: Are being treated for an infection, have an infection that won't go away or keeps coming back, or have symptoms of an infection, such as: - …
Dosing & Monitoring |UC| RINVOQ® (upadacitinib) - HCP
WEBRINVOQ is a once-daily pill that comes in three dosage strengths. One strength for induction and two strengths for maintenance. INDUCTION. The recommended induction …
RINVOQ® (upadacitinib) | For Healthcare Professionals
WEBRINVOQ® (upadacitinib) | For Healthcare Professionals. EXPECTATIONS. Challenge treatment goals. RHEUMATOLOGY. Rheumatoid Arthritis. for moderate to severe adult TNFi-IR patients. Psoriatic Arthritis. for adult …
Access & Patient Support | Rheumatoid Arthritis - RINVOQ HCP
- Gastrointestinal (GI) perforations have been reported in clinical trials with RINVOQ. Monitor RINVOQ-treated patients who may be at risk for gastrointestinal perforation (e.g., patients with a history of diverticulitis and patients taking NSAIDs or corticosteroids). Promptly evaluate patients presenting with new onset abdominal pain for early ident...
Rheumatoid Arthritis Treatment | RINVOQ® (upadacitinib)
WEBView info for healthcare professionals about RINVOQ®, a treatment for moderate to severe rheumatoid arthritis (RA) in adult TNFi-IR patients. See Important Safety Information, including BOXED WARNING.
Psoriatic Arthritis Treatment | RINVOQ® (upadacitinib)
WEB3 days ago · View information for healthcare professionals about RINVOQ®, a treatment for active psoriatic arthritis in adult TNFi-IR patients. See Important Safety Info, including BOXED WARNING. Psoriatic …
Rinvoq | European Medicines Agency
WEBRinvoq is a medicine that acts on the immune system (the body’s natural defences) and is used to treat: adults with moderate to severe rheumatoid arthritis (a disease that causes …
New Data Show RINVOQ® (upadacitinib) Demonstrated …
WEBApril 25, 2024. New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open …
How RINVOQ® (upadacitinib) Works - RINVOQ® for Crohn’s
WEB23 hours ago · You should not start taking RINVOQ if you have any kind of infection unless your HCP tells you it is okay. If you get a serious infection, your HCP may stop your …
Skip to content